Carcinogenesis of 4-aminobiphenyl in BALB/cStCrlfC3Hf/Nctr mice. 1985

G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger

Male and female (840 each) BALB/cStCrlfC3Hf/Nctr mice were given 0, 7, 14, 28, 55, 110 and 220, and 0, 7, 19, 38, 75, 150 and 300 ppm, respectively, of 4-aminobiphenyl in their drinking water. Necropsies on killed animals were performed at 13, 26, 39, 52 and 96 weeks on dose. Dose-related neoplasms were angiosarcomas, bladder urothelial carcinomas and hepatocellular neoplasms. The non-neoplastic dose-related lesions were left atrial thrombosis, bladder urothelial hyperplasia, splenic hemosiderosis and splenic erythropoiesis. The incidences of bladder carcinoma and atrial thrombosis were higher in the males and the incidences of hepatocellular neoplasms and angiosarcomas were higher in the females.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right
D006394 Hemangiosarcoma A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed) Angiosarcoma,Angiosarcomas,Hemangiosarcomas

Related Publications

G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
July 1999, IUBMB life,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
May 1992, Journal of cell science,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
November 2014, National Toxicology Program technical report series,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
December 1990, Cancer letters,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
August 1982, The American journal of pathology,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
April 1990, Tumori,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
October 1987, Cancer letters,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
August 1982, The American journal of pathology,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
January 2004, Report on carcinogens : carcinogen profiles,
G J Schieferstein, and N A Littlefield, and D W Gaylor, and W G Sheldon, and G T Burger
January 2011, Report on carcinogens : carcinogen profiles,
Copied contents to your clipboard!